Viraj Sanghvi
oncolab.bsky.social
Viraj Sanghvi
@oncolab.bsky.social
Cancer biologist and space enthusiast, asst. professor at @columbiacancer @columbia previously @umiamimedicine trained @DrexelUniv @MSKcancercenter.🇮🇳🇺🇸
Reposted by Viraj Sanghvi
Available online - the Spotlight "FN3K: the (un)sweetest kinase" from Viraj Sanghvi @oncolab.bsky.social and colleagues.

#ProteinPhosphorylation #ProteinGlycation #AdvancedGlycationEndProducts #AGE #SBDD

Read it here: authors.elsevier.com/a/1ktQO3S6Gf...
April 17, 2025 at 3:25 PM
Reposted by Viraj Sanghvi
Big thanks to Viraj for the lovely and thoughtful write-up on our collaboration with Leemor! And major shoutout to Yang from my lab for the gorgeous biochemistry—so proud! ✨👏🧪
Check out our article in @cp-trendsbiochem.bsky.social
highlighting the elegant work by Joshua-Tor lab, @davidlabmsk.bsky.social, and team .Their findings shed light on the structural basis of FN3K function and open doors for targeting glycation-related diseases. @sanniejculbertson.bsky.social
FN3K: the (un)sweetest kinase
Fructosamine 3-kinase (FN3K) mitigates excessive protein glycation by phosphorylating and destabilizing fructosamines, preventing irreversible advance…
www.sciencedirect.com
April 7, 2025 at 11:51 PM
Check out our article in @cp-trendsbiochem.bsky.social
highlighting the elegant work by Joshua-Tor lab, @davidlabmsk.bsky.social, and team .Their findings shed light on the structural basis of FN3K function and open doors for targeting glycation-related diseases. @sanniejculbertson.bsky.social
FN3K: the (un)sweetest kinase
Fructosamine 3-kinase (FN3K) mitigates excessive protein glycation by phosphorylating and destabilizing fructosamines, preventing irreversible advance…
www.sciencedirect.com
April 6, 2025 at 4:16 PM
Reposted by Viraj Sanghvi
This is dangerously irresponsible on every level. Indiscriminately slashing this funding will cripple lifesaving research on everything from cancer to opioid addiction.
NIH cuts billions of dollars in biomedical funding, effective immediately
The move halts a large slice of money for most universities and research institutions virtually overnight, imperiling vital research in everything from cancer to heart disease.
www.washingtonpost.com
February 8, 2025 at 6:28 PM
Congratulations to @obenaufa.bsky.social and the whole team for this very exciting story on immune suppression in cancer
December 16, 2024 at 2:30 PM
Reposted by Viraj Sanghvi
“NIH produces an astounding return on investment to the American taxpayer. In Fiscal Year 2022, NIH research funding supported 568,585 jobs and generated $96.84 billion in economic activity — that’s $2.64 of economic activity for every $1 of research funding.”
www.researchamerica.org/2023-oped-us...
Research supported by NIH has led more than 100 Nobel Prizes and has supported more than 99% of drugs approved by federal regulators from 2010 to 2019.
But come January, NIH may face a wrecking ball
nytimes.com/2024/12/01/h...
Long a ‘Crown Jewel’ of Government, N.I.H. Is Now a Target
nytimes.com
December 1, 2024 at 11:58 PM
Are you Interested in researching liver cancer or post-translational modifications - our group at Columbia University is expanding and we are looking for motivated postdocs
www.linkedin.com/jobs/view/40...
www.linkedin.com
November 21, 2024 at 3:37 PM
Reposted by Viraj Sanghvi
We are looking for a postdoctoral data scientist position to join our supportive and fun group :) Join us @QMBCI in vibrant #London to delve into the analysis of repetitive genome in #cancer! We support for visa applications, career and personal development! www.jobs.ac.uk/job/DFN649/p...
January 25, 2024 at 7:39 AM